Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Regulatory News (ORPH)

  • There is currently no data for ORPH

Total Voting Rights

6 Feb 2020 09:30

RNS Number : 1839C
Open Orphan PLC
06 February 2020
Β 

6 February 2020

Β 

Open Orphan plc

("Open Orphan", the "Company" or the "Group")

Total voting rights

Β 

In conformity with the FCA's Disclosure Guidance and Transparency Rules, following Admission of the Placing and Subscription Shares, the Company confirms that as at the time of this announcement, its issued share capital consists of 532,507,581 ordinary shares of 0.1 pence each ("Ordinary Shares"). All of the Ordinary Shares have equal voting rights and there are no Ordinary Shares held in treasury. This figure of 532,507,581 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

Capitalised terms in this announcement shall have the same meanings given to such terms in the Group's announcement at 7.00 a.m. on 31 January 2020.

Β 

For further enquiries, please contact:

Β 

Open Orphan plc

Cathal Friel, Executive Chairman +353 (0)1 644 0007

Trevor Phillips, Chief Executive Officer +44 (0)20 7347 5350

Β 

Arden Partners plc (Nominated Adviser and Joint Broker) +44 (0)20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer

Β 

Davy (Euronext Growth Adviser and Joint Broker) +353 (0)1 679 6363

Anthony Farrell

Β 

Camarco (Financial PR) +44 (0)20 3757 4980

Tom Huddart / Daniel Sherwen

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TVRFIFETFTIRIII
Date   Source Headline
10th May 20197:00 amRNSPreliminary Final Results
1st May 201911:00 amRNSChanges to interests of a significant shareholder
1st May 201911:00 amRNSIntegumen Debt Conversion
8th Apr 20197:00 amRNSFinancing Update
26th Mar 20197:00 amRNSChange of Adviser
21st Jan 20194:40 pmRNSSecond Price Monitoring Extn
21st Jan 20194:35 pmRNSPrice Monitoring Extension
18th Jan 20197:00 amRNSPartnership Announcement
24th Dec 201812:36 pmRNSPrice Monitoring Extension
21st Dec 20184:29 pmRNSDirector/PDMR Shareholding
20th Dec 20185:04 pmRNSHolding(s) in Company
11th Dec 20187:00 amRNSStrategic Collaboration Agreement and Financing
8th Nov 201810:40 amRNSTrading Update and Change of Adviser
5th Oct 20183:36 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
17th Sep 20187:00 amRNSFirst laboratory-grown human-skin test service
30th Jul 201811:27 amRNSHolding(s) in Company
26th Jul 20185:01 pmRNSHolding(s) in Company
26th Jul 20185:00 pmRNSHolding(s) in Company
26th Jul 20183:40 pmRNSHolding(s) in Company
24th Jul 20188:00 amRNSEnterprise Securities Market Notice
24th Jul 20188:00 amRNSEnterprise Securities Market Notice
20th Jul 20183:22 pmRNSResult of General Meeting
4th Jul 20187:00 amRNSPlacing & Subscription to raise up to £0.65m
28th Jun 201811:47 amRNSResult of AGM
6th Jun 20184:55 pmRNSNotice of AGM & Posting of Annual Report&Accounts
17th May 20187:00 amRNSFinal Results
23rd Apr 20187:00 amRNSNotice of Results
21st Mar 20187:00 amRNSDirectorate Change
15th Feb 20187:00 amRNSTrading Statement
25th Jan 20187:00 amRNSChange of Adviser
23rd Jan 20187:00 amRNSAcquisition of Minority Interest
14th Sep 20175:19 pmRNSGrant of Stock Options
12th Sep 20177:00 amRNSHalf-year Report
25th Jul 20177:00 amRNSSenior Management Appointment
20th Jul 20177:00 amRNSHalf year end update
26th Apr 20176:01 pmRNSResult of AGM
25th Apr 20173:13 pmRNSProposed amendment to AGM resolution
5th Apr 20177:00 amRNSIntegumen IPO
4th Apr 20177:00 amRNSEnterprise Securities Market Notice
31st Mar 201711:26 amRNSAnnual Financial Report & Notice of AGM
29th Mar 20171:57 pmRNSIssue of Equity
22nd Mar 20177:00 amRNSFinal Results
3rd Mar 20177:00 amRNSYear End Update
18th Nov 20167:00 amRNSCompletion of Sale
10th Nov 20165:51 pmRNSREPLACEMENT - Contract win
8th Nov 20167:00 amRNSContract win
2nd Nov 20167:03 amRNSDirector/PDMR Shareholding
27th Oct 20167:00 amRNSSale of Innovenn UK Limited and Result of GM
4th Oct 20167:00 amRNSSale of Innovenn & Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.